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Rates of psychological distress are high following diagnosis and treatment of brain tumor.
There can be multiple barriers to accessing psychological support, including physical and
cognitive impairments and geographical limitations. Tele-based support could provide an
effective and more flexible option for delivering psychological interventions. The present
study aimed to investigate the feasibility and utility of a telephone-based psychother-
apy intervention for people with brain tumor. A single-case multiple-baseline design was
employed with a 4–7-week baseline phase, 10-week treatment phase, and 5-week mainte-
nance phase including a booster session. Four participants with a benign or malignant brain
tumor (three males and one female; aged 34–49 years), received 10 sessions of tele-based
therapy and a booster session at 4 weeks post-treatment. Levels of depression, anxiety,
and illness cognitions were monitored on a weekly basis throughout each phase whilst
measures of quality of life, stress, and self-concept were administered at the start and
end of each phase. Weekly measures were analyzed using a combination of both visual
analysis and Tau-U statistics. Of the four participants, two of them demonstrated signifi-
cant gains in mental health (depression and/or anxiety) and a significant decrease in their
levels of helplessness (p<0.05). The other two participants did not show gains in mental
health or change in illness cognitions. All participants reported improvement in quality of
life post-treatment.The results of the study provide preliminary support concerning the fea-
sibility and utility of tele-based therapy for some people with brain tumor. Further research
examining factors influencing the outcomes of tele-based psychological support is needed.
Keywords: neuro-oncology, brain tumor, psychological distress, psychotherapy, telephone-based support,
counseling
INTRODUCTION
Levels of psychological distress following brain tumor diagnosis
are high, with 41–47% of people found to experience depres-
sion or anxiety beyond the primary treatment phase (1). There
are numerous practical barriers to people accessing face-to-face
(FTF) psychological support, including cognitive and physical dif-
ficulties, costs, and geographical distance. Despite this, there is very
limited research on the feasibility and efficacy of flexible delivery
modes of psychological intervention (e.g., telephone, internet).
Depression has been found to be consistently related to poor
quality of life for people with brain tumor (2–6). Some symptoms
of depression are likely to arise directly from the biological effects
of the tumor and its treatment (e.g., weight loss, sleep disturbance,
concentration difficulties). Other symptoms may develop in reac-
tion to the threat to life and stressors associated with functional
impairments and activity restrictions (7). In particular, people
with brain tumor experience a prominent sense of threat and
uncertainty about the future (8). For example, people with low-
grade glioma may live with relatively mild neurological symptoms
for many years and be able to perform normal occupational activi-
ties until the disease progresses and their functional state declines.
Conversely, people with a Grade IV glioma may not be able to
resume occupational roles and they often face a much shorter life
expectancy with rapid functional decline.
Adelbratt and Strang (9) identified a common theme of “death
anxiety,” which referred to the preoccupation with threat to life
experienced by the person with brain tumor and their next of kin.
Symptoms and gradual loss of functions were seen as metaphors of
dying and death (9). These illness appraisals can impact both phys-
ical and psychological health (10). Higher levels of psychological
distress are generally associated with perceptions of high threat or
helplessness and low levels of controllability or self-efficacy regard-
ing coping (11). For example, people with higher perceptions of
threat and lower perceptions of controllability 2 weeks after stroke
had poorer psychological adjustment at 6 months post-stroke (12).
With the combined effects of brain injury and cancer, brain
tumor poses some unique stressors. Cancer is often considered
uncontrollable and highly threatening, with limited potential for
benefit (10, 13, 14). Most people experience tumor re-growth
or progression and functional decline. The physical, cognitive,
and behavioral impairments associated with the tumor and its
treatment lead to increased dependence on others, relationship
strain, and inability to resume valued activities (e.g., driving and
work). Experiencing a sense of threat and low controllability
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in combination with severe functional impairments can have a
devastating impact on quality of life.
Antonovsky’s (15) sense of coherence (SOC) model has been
applied to understand how people strive to maintain well-being
in the context of adversity. The SOC model proposes that three
components, namely, comprehensibility (understanding of what
is happening), manageability (perceived ability to access resources
to cope), and meaningfulness (capacity to find meaning within
the situation) influence people’s psychological and physical well-
being. In support of this model, stronger SOC has been found
to be protective against the development of depression and anx-
iety in people with cancer and their partners (16). Further,
there is evidence to suggest that SOC can be enhanced through
intervention (17, 18).
Closely related to the concept of SOC, Salander et al. (19) found
that people with malignant glioma varied in their“time of everyday
life,” or level of engagement in activities that were similar to those
prior to their diagnosis, and “time of disease” or extent to which
they were occupied with the disease and its treatment. One-third
of working age patients described a loss of life continuity, only
experiencing “time of disease”; these patients reported an absence
of everyday living. The remaining two-thirds of individuals were
found to have spent a period focusing on “time of life” before they
progressed to “time of disease.”“Time of life” included work, hob-
bies, and activities of daily living which serve to maintain a sense
of connection to everyday life, and foster hope, not of a cure, but
of a remaining life not dominated by disease and death.
Overall, this research highlights that interventions focusing on
making sense of, finding meaning, and participation in meaningful
“time of life” activities have the potential to enhance psycholog-
ical adjustment and quality of life after brain tumor. Despite the
well-recognized need for psychological support for people with
brain tumor and their families, there is limited published research
on the efficacy of interventions (4, 8, 20–22). Controlled trials of
psychological interventions for people with cancer have typically
excluded people with brain tumor or those with cognitive dys-
function (23–25), thus limiting the capacity to generalize findings
from the general cancer literature.
A review of counseling and rehabilitation interventions for
adults with brain tumor identified 13 studies, which included
6 case studies or case series (see Table 1), 4 RCTs, and 3 pre-
post group studies with no control group (see Table 2). Overall,
there was evidence of gains in psychological well-being from case
studies. However, although the controlled trials of cognitive reha-
bilitation demonstrated some gains in cognitive functioning and
strategy use (21, 26, 27), such gains did not extend to psychological
well-being or quality of life. This suggests that rehabilitation focus-
ing on cognitive impairments may not be sufficient to improve
broader psychosocial well-being. Promisingly, a recent study pro-
tocol (28) described a study underway that is investigating the
efficacy of internet-based guided self-help for people with glioma
with mild to moderate depression.
The first RCT of a psychotherapy intervention for people with
brain tumor was conducted by Ownsworth and colleagues (37).
The 10-session Making Sense of Brain Tumor (MSoBT) inter-
vention (n= 50) was home-based, goal-directed, and guided by
principles of the SOC model. Although the focus of support was
mainly on the person with brain tumor, involvement of family
members was strongly encouraged and 60% of programs involved
a family member who attended 1–10 sessions. An evaluation of
post-intervention outcomes identified that participants with brain
tumor experienced significantly lower levels of depression and
higher levels of existential well-being and global quality of life rel-
ative to wait list controls. At the 6-month follow-up, participants
were found to have significantly better psychological well-being
than prior to the intervention (37).
Despite the promising psychological outcomes of the FTF
MSoBT intervention, the program was both time and cost inten-
sive. The authors identified that to maximize participant engage-
ment, practitioners often drove over an hour to provide an
Table 1 | Summary of case studies evaluating psychological interventions for people with brain tumor.
Reference Intervention Tumor
characteristics
n Intervention outcomes
Rao and
Bieliauskas (29)
Psychological (16 couple sessions) and cognitive
retraining (16 sessions)
Grade II–III 1 Improvements in neuropsychological functioning and
behavior (e.g., social interactions, leisure, driving
skills), and efficiency on work tasks
Sherer et al. (30) Cognitive and vocational rehabilitation in clinic and
community setting
High grade 13 Gains in independence for six participants (six
remained the same, one declined) and productivity for
eight participants (four remained the same, one
declined) which was maintained at 8-month follow-up
Kowal et al. (31) Emotion-focused couples therapy (12 sessions) Low grade 1 Description of positive psychological outcomes
Tepper (32) Psychosocial support High grade 4 Description of positive psychological outcomes
Duval et al. (33) Cognitive and ecological rehabilitation (26
sessions), information meetings (two sessions)
Grade II 1 Improvement in working memory at 3-month
follow-up with generalization to everyday life
Whiting et al. (34) 2-h session of psychoeducation, communication,
and relaxation skills training
Grade II 1 Decrease in target behavior and increase in
knowledge of strategy use
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Table 2 | Summary of group studies evaluating psychological interventions for people with brain tumor.
Reference Intervention Design and sample
characteristics
n Intervention outcomes
Locke et al.
(21)
12 sessions of cognitive
rehabilitation (CR) and
problem-solving therapy vs.
standard medical care
RCT; mixed
grades
19 Positive feedback from people with brain tumor and caregivers on the
program; 88% used compensation strategies and 88% found the
intervention helpful. No significant differences on quality of life
(QOL), functional capacity, mood, or fatigue between control and
intervention group at 3-month follow-up
Gehring
et al. (26)
CR (retraining and compensation,
six sessions); 3-month
telephone-based booster
RCT with waiting
list; Grade II and
III
140 Significant effects at post-treatment for subjective cognitive function
and perceived burden; not maintained at 6-month follow-up. At
6-month follow-up, significant gains on tests of attention and verbal
memory and improvements with mental fatigue
Hassler
et al. (35)
10 sessions of group cognitive
training (attention, verbal, and
memory skills) over 12 weeks
Pilot study with
no control group;
Grade III and IV
11 Significant improvement in verbal memory at post-intervention
Zucchella
et al. (27)
16 sessions of CR for 4 weeks RCT; mixed grade 58 Significant improvement in cognitive functioning at post-intervention
Khan et al.
(36)
Individualized social support
program: interview plus peer
support or community
education/counseling
Prospective
longitudinal
pre-post design;
mixed grade
43 Significant improvements in psychological functioning, physical QOL,
coping strategies, functional, and cognitive independence at 6-week
follow-up. Gains in anxiety, stress, and QOL were not maintained at
6-month follow-up, although broader psychosocial gains were
maintained long-term
Ownsworth
et al. (37)
10 sessions of home-based
psychotherapy
RCT with wait
list; mixed grade
50 Significantly reduced depression and improvements in existential
well-being and QOL at post-intervention and 6-month follow-up
intervention for the person with brain tumor and his or her family
members (37). Such travel time may not be feasible for service
delivery within the community. Furthermore, due to travel time,
the program was restricted to people living within a major metro-
politan area. To reduce such barriers to accessing psychotherapy,
tele-health may be an option for service provision.
Telephone-based and internet interventions are increasingly
being utilized to reduce barriers to accessing psychotherapy.
A meta-analysis by Andersson and Cuijpers (38) for internet
and other computerized psychological treatments for depression
found a moderate to large average effect size (d = 0.41) across 12
studies. The authors noted that the studies that provided some
form of direct therapist support to participants (e.g., email, tele-
phone contact, or additional FTF contact) yielded larger effect sizes
(d = 0.61). Hammond and colleagues (39) compared the clini-
cal and cost-effectiveness of FTF and over-the-telephone (OTT)
low-intensity CBT interventions for mild to moderate anxiety and
depression (n= 4,106). They found that outcomes of the OTT and
FTF interventions were comparable, with the exception of those
with more severe illness, where FTF was found to be more effec-
tive. The service costs of OTT were found to be approximately
one-third lower than FTF sessions (39). The researchers proposed
that OTT interventions are a convenient and effective mode of
delivery for those requiring low-intensity interventions (39).
From a practical perspective, tele-based therapy may result in
lower attrition and greater access to psychological therapy for
people restricted by mobility or geography. In a meta-analysis of
FTF therapies between 2000 and 2010, Swift and Greenberg (40)
reported mean attrition rates of 19.7%. In contrast, Mohr and
colleagues (41) found that the mean attrition rate across 12 RCTs
of tele-based psychotherapy for depression was only 7.6%. Tele-
based psychotherapy has been shown to be effective for improving
emotional adjustment for people with multiple sclerosis (42),
HIV-AIDS (43), depression (44), and traumatic brain injury (45).
Such findings support the potential utility of telephone-based
psychotherapy for people with a brain injury.
Whilst tele-based therapy may increase the opportunity for
people with brain tumor to access psychotherapy,neuropsycholog-
ical impairments such as language difficulties, memory problems,
distractibility, and difficulties with sustained attention may pose
a barrier to engagement and efficacy for treating mood problems.
Psychotherapy relies upon on verbal communication, including
understanding of spoken and written information. Tele-based
therapy does not allow for the use of visual aids and techniques
(such as diagrams or handouts) to support understanding of con-
cepts. Instead, there is reliance on auditory communication in
terms of both verbal and non-verbal responses (e.g., sighs, cry-
ing, and laughing), which may affect the therapeutic alliance (46).
Telephone-based therapy also has the increased potential for inter-
ruptions and distractions, particularly when conducted in the
person’s home. In addition, family members may have more diffi-
culty engaging in the therapeutic process. Therefore, an evaluation
of the feasibility and utility of telephone-based therapy for people
with brain tumor is clearly warranted.
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Accordingly, the broad aim of the present study was to evalu-
ate the feasibility and utility of a telephone-based psychotherapy
intervention for people with brain tumor. The present study seeks
to extend on the previous FTF MSoBT intervention for peo-
ple with brain tumor (37). An additional booster session was
included 2 weeks after the 10-session program to support main-
tenance and generalization of gains (47). In relation to utility,
it was hypothesized that telephone-based psychotherapy would
result in a significant decrease in levels of depression, anxiety, and
hopelessness between the baseline and treatment phase (as mea-
sured weekly), which would be maintained at 5 weeks follow-up.
Additionally, it was hypothesized that there would be a significant
increase in levels of acceptance and perceived benefit between the
baseline and treatment phase (as measured weekly), and that these
gains would be maintained at 5 weeks follow-up. Broader gains in
quality of life and self-concept were also assessed.
MATERIALS AND METHODS
DESIGN
A single-case experimental design (SCED) with multiple baselines
across participants (see Figure 1) was used to examine the impact
of a telephone-based therapeutic intervention on psychological
well-being. Single-case methodology is beneficial when evaluating
a new treatment in conditions that are rare, in which it is dif-
ficult to obtain large samples with homogenous characteristics.
The design entails repeated measurements of functioning over
time to evaluate the impact of treatment relative to the baseline
period (48).
Multiple-baseline designs reduce the likelihood of extrane-
ous, potentially confounding factors influencing the results (49,
50). Beeson and Robey (51) recommended a minimum baseline
of three data points to control for threats to validity. Utilizing
repeated observation prior to the commencement of the inter-
vention allows for analysis of trends in the data both within
and between phases. In the present study, there was a mini-
mum of four baseline data points (random allocation P1) and
a maximum of seven baseline data points (random allocation
P4), prior to the 10 treatment sessions. Participants were ran-
domly allocated to baseline length (four, five, six, or seven) using
a pre-determined randomized computer sequence with concealed
allocation of numbers placed in sealed opaque envelopes (50).
PARTICIPANTS
In the earlier MSoBT program [see Ref. (37)], individuals with
primary brain tumor were recruited through major hospitals, neu-
rosurgery clinics, and community services supporting people with
cancer and brain injury. When the FTF MSoBT program ceased
recruitment, participants inquiring about the initial program after
July 2012 were referred to the telephone-based program. Adults
with a primary brain tumor were eligible to participate in the
study, irrespective of their tumor type and status. Participants
were eligible from across Queensland. Participants undertaking
current psychological interventions related to the effects of their
brain tumor were not eligible to participate. Very severe cognitive
deficits or receptive and/or expressive language deficits were con-
sidered likely to preclude telephone-based assessment or therapy.
A telephone-based cognitive assessment tool was used to screen
for cognitive and language deficits to determine eligibility. Addi-
tional eligibility criteria included ongoing access to a telephone,
availability for weekly telephone assessment and therapy over a
20–24-week period (inclusive of baseline, treatment, and main-
tenance phases), and no significant hearing deficits that would
preclude the use of a telephone.
A sample of four participants was considered an appropriate
number for a SCED with the length of baseline varying from 4 to
7 weeks. The demographic and medical characteristics of the four
participants (Mark, John, Robyn, and Samuel) are summarized in
Table 3. More details of the health, cognitive, and psychological
status of each participant is provided in the Section “Results.”
MEASURES
Cognitive screening
In the initial telephone session, participants completed the brief
test of adult cognition by telephone [BTACT; (52)] to screen for
very severe cognitive deficits that were considered likely to affect
people’s capacity to engage in the intervention program. The
BTACT is a brief (20 min) test of auditory attention, processing
speed, memory, verbal fluency, and reasoning. In this study, five of
the seven subtests were completed as follows:Word List Recall,Dig-
its Backward, Category Fluency, Backwards Counting, and Short-
Delay Recall. The BTACT has sound psychometric properties and
has been validated in the general population (n= 4268).
Results on the BTACT indicated that Samuel performed in
the “below average” range relative to age norms on measures of
immediate and delayed memory, verbal fluency, and processing
speed. Robyn’s scores indicated “below average” performance on
a delayed verbal memory task and Mark’s scores indicated “below
average”performance on a verbal fluency task. John’s performance
was in the “average” range for all five domains. Although Samuel
demonstrated age-related impairments on four cognitive tasks
(i.e., >1 to <2 SD below the norms), he was considered to have
Phase A B C
P1 x x x x + T1 … x + T10 x x x x + T11 x x
P2 x x x x x + T1 … x + T10 x x x x + T11 x x
P3 x x x x x x + T1 … x + T10 x x x x + T11 x x
P4 x x x x x x x + T1 … x + T10 x x x x + T11 x x
FIGURE 1 | Multiple baselines across participants design [A, baseline; B, treatment; and C, maintenance and booster (T11) session].
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Table 3 | Summary of participants’ demographic and health characteristics.
Characteristics Marka (P1) Johna (P2) Robyna (P3) Samuela (P4)
Age (years) 43 34 49 40
Gender Male Male Female Male
Highest level of education Post-secondary school diploma Secondary (high school) Undergraduate degree Undergraduate degree
Current employment Part-time Part-time Full-time Full-time
Current relationship status Divorced, no children Married, three children Divorced, two children Single, no children
Time since diagnosis 13 years 2.5 years 3 months 16 years
Brain tumor type Cystic astrocytoma Anaplastic astrocytoma Pituitary tumor Oligoastrocytoma
Tumor malignancy Grade I Grade III Grade I Grade II
Brain tumor location Hypothalamus/optic pathway Left temporal lobe Pituitary gland Left temporal lobe
Treatment/s Surgery Surgery Surgery Surgery
Radiotherapy Radiotherapy Hormone replacement therapy Radiotherapy
chemotherapy chemotherapy
Anti-convulsants Anti-convulsants
Geographical location Regional Regional Metropolitan Metropolitan
Ability to drive Yes Yes No No
aPseudonym used to protect participant’s identity.
adequate cognitive functioning to undertake a telephone-based
therapy program.
Psychological outcomes
At the start and end of each phase, participants completed the
full set of self-report measures, including the 21 item Depression,
Anxiety, and Stress Scale [DASS-21; (53)], Generalized Anxiety
Disorder Scale [GAD-7; (54)], FACT-Brain (55), Illness Cognition
Questionnaire [ICQ; (10)], and Continuity and Discontinuity of
Self Scale [CDSS; (56)]. The brief set of outcome measures for
session-by-session assessment included the depression scale of
the DASS-21, GAD-7, and ICQ. The Session Rating Scale [SRS;
(57)] was completed after every therapy session (from session two
onward) to assess therapeutic alliance.
Mood state. The seven-item depression subscale of the DASS-
21 was designed to assess symptoms of depression and has been
validated for use with people with brain tumor (7). The clinical
cut-offs are: normal, ≤9; mild, 10–13; moderate, 14–20; severe,
21–27; and extremely severe, ≥28. The GAD-7 is a measure of
symptoms of generalized anxiety disorder which has been vali-
dated in primary care settings (54) and the general population
(58). The clinical cut-offs for the scale are: normal,<5; mild, 5–9;
moderate, 10–14; and severe,≥15.
Illness cognitions. The ICQ is an 18-item measure of illness cog-
nitions for people with chronic disease (10). It was modified in this
study so that items applied to brain tumor (i.e., the word “illness”
was replaced with “tumor”). The subscales measure helplessness
(e.g., “Because of my tumor, I miss the things I like to do most”),
acceptance (e.g., “I can handle problems related to my tumor”),
and perceived benefits (e.g., “Dealing with my tumor has made
me a stronger person”). Higher scores indicate increased levels of
helplessness, acceptance, or perceived benefits.
Quality of life. The FACT-G (33 items) is comprised of four sub-
scales that assess physical, social/family, emotional, and functional
well-being aspects of health-related quality of life (55). An addi-
tional subscale developed by Weitzner and colleagues (59) assesses
brain-related concerns. Higher scores indicate increased quality of
life, with scores ≥0.5 SD below the norms (M = 80.1, SD= 18.1)
indicating low quality of life (55).
Self-concept. The CDSS (24 items) assesses discontinuity of self
(e.g., “I sometimes give up on something because it is too much
trouble”), continuity of self (e.g., “I have control of my life”), and
continuity with others (e.g., “I feel accepted by others”). Higher
scores indicate greater levels of discontinuity of self (range= 1–
36) or continuity of self (range= 1–15) and continuity with others
(range= 0–21). Originally developed for the stroke population,
the CDSS was considered suitable for use with people with brain
tumor based on research indicating that sense of self and life
continuity can often be disrupted (19).
Therapeutic alliance. The SRS,Version Three (57) was converted
to an 11-point scale (e.g., 0,“I did not feel heard, understood,
and respected” to 10,“I felt heard, understood, and respected”) to
assess: (1) quality of the relational bond, (2) agreement between
the individual and therapist regarding the goals, and (3) agreement
on the method and approach used.
PROCEDURE
Ethical clearance was obtained from the Griffith University Human
Research Ethics Committee (PSY/37/10/HREC) as part of the
larger MSoBT project. During the initial screening process, demo-
graphic and medical information was obtained from participants
(e.g., tumor type, time since diagnosis, age, gender, and employ-
ment status). Participants were provided with details about the
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study OTT and through written information posted to them. Par-
ticipants returned a signed consent form prior to commencing the
study.
Participants were randomly allocated to one of the four base-
lines lengths. Numbers (4–7) corresponding to the length of
baseline were placed in sealed opaque envelopes and then ran-
domly ordered. The envelopes were opened in consecutive order
as each participant entered the study. Prior to commencing the ini-
tial assessment, participants were posted a booklet of the outcome
measures for ease of administration. The booklet also contained
a copy of the consent form, SRS, and plastic sleeves for partici-
pants to store any notes they made. The booklet was divided into
sections for ease of use.
After allocation, the researcher conducted the initial assessment
session, which included the BTACT and full set of outcome mea-
sures. Participants were assessed on a weekly basis on a brief set
of outcome measures (“brief”) for the duration of their allocated
baseline (see Figure 2). Prior to the commencement of therapy,
participants were re-administered the full set of outcome mea-
sures, with the exception of the BTACT. During therapy, partici-
pants completed the brief set of outcome measures at the start of
the telephone call, just prior to therapy. Participants subsequently
completed 10 sessions of individual telephone-based therapy with
an additional booster session 4 weeks after their completion of the
10 sessions.
The SRS was completed after each telephone-based therapy ses-
sion from session two onward, including the booster session. The
full set of outcome measures was re-administered after the com-
pletion of the 10 telephone-based therapy sessions and again at the
end of the maintenance phase, 6 weeks later, as seen in Figure 2.
THERAPEUTIC INTERVENTION
Consistent with the FTF program, 1 h telephone therapy sessions
comprised of both core (sessions 1, 2, and 10) and individualized
components, with the latter tailored to each participant’s specific
therapy goals and life circumstances. During the initial session,
participants described their experience of symptom onset, diag-
nosis, treatment, and the impact of the tumor and its treatment on
daily living (i.e.,“telling my story”). Session two explored personal
values and associated goals and priorities. From the information
gained and rapport built during sessions one and two, three to five
therapy goals were collaboratively set. Goals most typically related
to understanding the effects of the brain tumor, learning strategies
to manage negative emotions and cognitive difficulties, improv-
ing relationships, and increasing social participation and healthy
lifestyle behaviors.
The tenth session summarized the main content of prior ther-
apy sessions and involved reflecting on gains and progress. A
plan for maintaining skills and managing set-backs was also a
focus of the session. The booster session also focused on mainte-
nance of strategy use and skills generalization and discussed issues
associated with termination of therapy.
Individual treatment modules included: psychoeducation on
the brain and brain tumor, cognitive rehabilitation and asso-
ciated strategies (e.g., memory and organization), cognitive-
behavior therapy, psychoeducation on emotional and behavioral
changes (e.g., symptoms of anxiety, depression, and panic attacks),
mindfulness techniques (e.g., mindful eating, present focused
awareness), pleasant activity scheduling, relaxation techniques
(e.g., progressive muscle relaxation, abdominal breathing), cou-
ple and family support (communication, problem-solving), and
existential and end-of-life discussions (i.e., family care plan).
DATA ANALYSIS
The analysis of the weekly repeated measures was conducted via a
combination of visual inspection, and a Tau-U tool [singlecasere-
search.org; (60, 61)]. Steps to data analysis for the weekly mea-
sures included: checking relevant assumptions for SCED, analysis
of baseline stability, and case-level analysis, including evaluation
of treatment effects within phase. Data on broader subjective
well-being measures was not subject to statistical analysis due to
insufficient data points.
The Tau-U is a statistical approach derived from the Kendall
Rank Correlation and Mann–Whitney-U tests, providing a com-
bined index of non-overlapping data between two conditions
(phases) and examination of trends both within and across phases.
This type of analysis has been recommended for simple AB designs
with particular strengths in controlling for baseline trend and vari-
ability, ceiling and floor effects, and has sensitivity to phase change
when data have been collected over a short period of time, irre-
spective of baseline length (60). The Tau-U allows for analysis of
baseline stability (A) and controls for trend. The analysis provides
Time
Brief Set of Outcome Measures (weekly)
Baseline (A) Treatment (B) Maintenance + Booster (C)
BTACT
SRS SRS
Full FullFull Full
Ini!al Session Session Booster
s
er
us
a
e
M
P
h
a
se
FIGURE 2 | Phases of the intervention program and assessment time points (SRS, Session Rating Scale).
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a more accurate evaluation of non-overlap or “dominance” of one
phase over another (AB) than mean or median differences. The
Tau-U has been found to have good statistical power for short
data series and is robust to outliers or extreme scores (60). Tau-U
is also relatively resistant to the effects of autocorrelation or seri-
ally correlated residuals, as demonstrated through field testing of
382 published data series, comparing the results before and after
cleansing for autocorrelation (60).
Visual analysis allows for inspection as to whether there has
been an observable change on the dependent variable by an inter-
vention (62,63). This method was used in conjunction with Tau-U,
clinical cut-offs, and normative data.
RESULTS
ANALYSIS OF BASELINE STABILITY
Three participants consistently scored within the clinical range
for depression during the baseline phase, albeit there was some
variability. As shown in Figure 3, Mark and Robyn’s scores varied
between “moderate” and “severe” levels whilst John and Samuel’s
scores ranged from “normal” to “severe.” There was also variabil-
ity in anxiety scores for all four participants (see Figure 4). Mark’s
scores ranged between the “normal” and “mild” range. John and
Samuel’s scores varied between “mild” and “severe” levels of anxi-
ety, whilst Robyn’s scores were in the “moderate” to “severe” range
during the baseline phase. Three participants had scores consis-
tently within the clinical range for anxiety during the baseline
phase. Visual inspection of the ICQ data in Figure 5 indicated
most variability on the helplessness scale for Mark and on the
acceptance scale for John and Samuel. Robyn’s scores on the three
ICQ scales appeared relatively stable.
CASE DESCRIPTIONS AND EVALUATION OF TREATMENT EFFECTS
Mark
Mark had been diagnosed with a Grade I cystic astrocytoma near
the hypothalamus 13 years ago. He was diagnosed after undergo-
ing a routine pre-employment medical assessment overseas, which
identified visual difficulties. He was told that he did not have long
to live and was advised against further medical treatment. After
further research into treatment, Mark underwent radiotherapy,
which reduced the size of the tumor, and he subsequently had
a partial resection. Since diagnosis, Mark reported a change in
his personality and anger outbursts. His marriage broke down
during the earlier years after his diagnosis and he has since had
difficulty making friends and forming relationships. He reported
some strained relationships with his family and a major loss when
his mother died. He also reported ongoing difficulties with bal-
ance and strength (impacting on recreational activities) and a skin
condition that affects his self-esteem and confidence. Mark was
referred to the program by a family member who was concerned
about how he was coping.
An analysis of the baseline phase identified no significant
trend in DASS depression levels (Tau-U = 0.5, p= 0.308). A
comparison of between phase variability (AB) indicated no sig-
nificant difference between the baseline and treatment phases
(Tau-U =−0.1, p= 0.777). Mark’s scores were consistently in
the clinical range for depression (“mild” to “moderate”) with a
notable increase between baseline assessments two and three (see
Figure 3). During treatment, depressive symptoms were reduced
between sessions two and three, with a subsequent increase in
symptoms from sessions four to seven (i.e., “extremely severe”
range). After session eight, his depression levels reduced to the
“mild” range, until the end of treatment. During the maintenance
phase, Mark’s depression scores varied between the “normal” and
“moderate” ranges.
There was no significant trend in Mark’s GAD-7 anxiety levels
in the baseline phase (Tau-U = 0.5, p= 0.308). Phase compari-
son (AB) indicated no significant difference between baseline and
treatment phases (Tau-U = 0.625,p= 0.077). During the baseline,
treatment, and maintenance phases, Mark’s anxiety levels ranged
between “normal” and “mild” levels (see Figure 4).
On the ICQ, there was no significant trend in Mark’s
baseline phase for levels of helplessness (Tau-U = 0, p= 1),
acceptance (Tau-U = 0.333, p= 0.497), or perceived benefit
(Tau-U =−0.167, p= 0.734). Phase comparison for helplessness
identified no significant difference between baseline and treat-
ment phases (Tau-U =−0.325, p= 0.358). Yet, over the course
of treatment and maintenance phases, a gradual reduction in
helplessness was observed (see Figure 5). Phase comparisons for
levels of acceptance and perceived benefit were found to be signif-
icant between the baseline and treatment phases (Tau-U =−0.85,
p= 0.016; Tau-U =−0.9, p= 0.011). Contrary to the hypothesis,
Mark’s level of acceptance and perception of benefits associated
with his brain tumor declined during the treatment phase.
On the measures of broader subjective well-being, Mark’s scores
on the FACT-G improved during the baseline period (as shown in
Table 4). This improvement mainly occurred on the social/family
and functional well-being subscales. His initial baseline FACT-G
score suggested low quality of life relative to the norms, which
improved to within the “average” range for the normal popula-
tion. On completion of the program, Mark’s scores remained in
the normal range. There was a small improvement in self-concept
(i.e., increase in continuity with others and decreased discontinuity
of self).
Mark reported high levels of therapeutic alliance on the SRS.
For all sessions, Mark consistently rated the alliance (relation-
ship, goals and topics, approach or method, and overall) at the
maximum score (10).
Overall, visual and statistical analysis of Mark’s psychologi-
cal functioning indicated limited therapeutic benefits in terms of
reducing his levels of depression and anxiety. Minor improve-
ment in helplessness was found, although this coincided with
decreased acceptance and perceived benefits. Minor improvements
in social and functional well-being and self-concept were also
reported.
JOHN
John was diagnosed with a Grade III anaplastic astrocytoma after
a grand-mal seizure 2 years prior to the program. He reported that
the seizure and diagnosis of brain tumor was unexpected and sud-
den, with no history of illness or need for medical attention. John
underwent immediate debulking surgery, with subsequent rounds
of chemotherapy and radiotherapy. He reported very little recol-
lection of these events. Following treatment, John reported infre-
quent seizures and ongoing concerns about his limited memory
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FIGURE 3 | Depression (DASS-21) levels across the three phases, with clinical cut-off for “mild” range (as indicated by broken line).
of the diagnosis and events since the diagnosis. His main concern
was that his brain tumor would preclude him from taking part
in everyday activities and that those around him would treat him
differently. John was also distressed about being a burden on his
family and felt guilty that he needed rest breaks during the day.
He also expressed grief that he would be unable to see his chil-
dren grow old and achieve milestones (e.g., school graduations,
birthdays, and weddings).
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FIGURE 4 | Anxiety (GAD-7) levels across the three phases, with clinical cut-off for “mild” range (broken lines).
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FIGURE 5 | Illness cognition levels on the Illness Cognition Questionnaire (ICQ) across the three phases.
There was no significant trend in John’s DASS depression scores
in the baseline phase (Tau-U =−0.1, p= 0.807). A compari-
son of between phase variability (AB) indicated no significant
difference between the baseline and treatment phases (Tau-
U =−0.1, p= 0.760). Visual inspection of the treatment phase
identified that after the initial treatment session of “telling my
story,” depression scores were in the “mild” range with scores
reducing to the “normal” range for the remainder of the treatment
phase and the maintenance phase.
No significant trend in GAD-7 anxiety levels was found in the
baseline phase (Tau-U = 0.7, p= 0.086). Phase comparison indi-
cated a significant reduction in anxiety between the baseline phase
and treatment phase (Tau-U =−0.92, p= 0.005). Baseline scores
ranged between “mild” and “severe” whilst scores in the treatment
phase were in the “normal” to “mild” range. During the mainte-
nance phase, John’s level of anxiety was in the “normal” range with
the exception of maintenance session five, for which his score was
in the “mild” range.
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Table 4 | Broader subjective well-being scores for Mark across phases.
Measure Initial
baseline
(A)
Final
baseline
(A)
End of
treatment
(B)
End of
maintenance
(C)
FACT-Brain
Physical 24 25 24 23
Social/family 11 15 17.5 14
Emotional 18 18 17 21
Functional 13 16 14 16
G 66 74 72.5 72
Brain 33 34 34 35
CDSS
Discontinuity self 34 33 33 31
Continuity self 13 11 15 12
Continuity others 19 18 20 21
On the ICQ, there was no significant trend in the baseline
phase for John’s levels of helplessness (Tau-U = 0.3, p= 0.462),
acceptance (Tau-U = 0.0, p= 1), or perceived benefit (Tau-
U =−0.2, p= 0.624). Phase comparison indicated a significant
difference in illness cognitions between the baseline and treat-
ment phases, which reflected a decrease in level of helplessness
(Tau-U =−0.92, p= 0.005) and an increase in acceptance (Tau-
U = 0.66, p= 0.043). Phase comparisons for perceived benefits
indicated no significant difference between baseline and treatment
phases (Tau-U = 0.08, p= 0.807).
Between the initial baseline assessment and final baseline assess-
ment, John’s scores declined on the FACT-G (see Table 5), indi-
cating low quality of life relative to the norms. However, on
completion of the program, John’s scores had markedly increased
from 72 to 98. At the end of treatment and maintenance phases,
John reported minor improvements in self-concept (i.e., increased
continuity of self, increased continuity with others, and decreased
discontinuity of self).
John reported high levels of therapeutic alliance on the SRS
throughout treatment [relationship (M = 8.8, SD= 0.91), goals
and topics (M = 9, SD= 0.66), approach or method (M = 9,
SD= 0.66), and overall (M = 9.2, SD= 0.78)].
In summary, visual and statistical analysis of John’s psychologi-
cal functioning indicated a significant reduction in levels of anxiety
and helplessness and increased levels of acceptance. There were
no significant changes in John’s levels of depression or perceived
benefits. Improvements in self-concept and quality of life were also
observed.
ROBYN
Robyn reported a gradual onset of symptoms, including visual
difficulties, facial numbness, right-sided numbness, lower limb
edema, abnormal menstruation, emotional blunting, and signifi-
cant weight gain. After 12 months of symptoms, Robyn was diag-
nosed with a benign (Grade I) pituitary tumor near the optic
nerve. She had key-hole surgery 3 days after her initial neuro-
surgical consultation. On entry to the program 3 months post-
diagnosis, Robyn reported difficulty coping with returning to
full-time employment and part-time study. She reported concerns
Table 5 | Broader subjective well-being scores for John across phases.
Measure Initial
baseline
(A)
Final
baseline
(A)
End of
treatment
(B)
End of
maintenance
(C)
FACT-Brain
Physical 17 14 16 23
Social/family 20 20 21 25
Emotional 16 15 17 23
Functional 20 17 18 27
G 73 66 72 98
Brain 37 36 49 34
CDSS
Discontinuity self 28 28 28 23
Continuity self 11 5 13 15
Continuity others 18 21 21 21
that her illness was invisible to others (i.e., family, friends, and col-
leagues) as there was no physical injury or sign of surgery. She also
found it difficult to cope with heightened emotionality as prior to
the surgery she had experienced emotional blunting. She reported
being unhappy in her job, having a limited support system, and
strained relationships with family members.
No significant trend was found in DASS-21 depression scores
across the baseline phase (Tau-U = 0.2, p= 0.573). A comparison
of between phase variability (AB) indicated no significant differ-
ence between the baseline and treatment phases (Tau-U = 0.333,
p= 0.278). Robyn’s scores were consistently in the clinical range
for depression, with scores mainly between the “moderate” and
“severe” range, although there was a notable increase to an
“extremely severe” level of symptoms after the third treatment
session.
There was no significant trend in GAD-7 anxiety scores in
the baseline phase (Tau-U = 0.333, p= 0.348). Phase compari-
son indicated no significant difference between the baseline and
treatment phases (Tau-U =−0.033, p= 0.914). Visual inspection
identified scores consistently between the “moderate” and “severe”
range across all phases.
On the ICQ, there was no significant trend in the base-
line phase for Robyn’s levels of helplessness (Tau-U = 0.333,
p= 0.348), acceptance (Tau-U = 0.333, p= 348), or perceived
benefit (Tau-U = 0, p= 1). Phase comparison for helplessness
and perceived benefits indicated no significant difference between
the baseline and treatment phases (Tau-U = 0.118, p= 0.704;
Tau-U =−0.183, p= 0.551). Phase comparison for acceptance
revealed a significant decrease in Robyn’s level of accep-
tance between baseline and treatment phases (Tau-U =−0.8,
p= 0.009).
Between the initial baseline assessment and final baseline assess-
ment, Robyn’s scores declined on the FACT-G (see Table 6), this
decline occurred across all subscales, suggesting low quality of
life relative to the norms. However, on completion of the pro-
gram, Robyn’s scores had increased, with further improvements
at the end of the maintenance period, reflecting improved quality
of life. Between the initial and final baseline assessments, Robyn’s
scores showed slight decline in self-concept (i.e., continuity with
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Table 6 | Broader subjective well-being scores for Robyn across
phases.
Measure Initial
baseline
(A)
Final
baseline
(A)
End of
treatment
(B)
End of
maintenance
(C)
FACT-Brain
Physical 15 12 17 20
Social/family 18 15 17 17
Emotional 15 14 9 14
Functional 15 17 19 20
G 63 58 62 71
Brain 52 60 60 63
CDSS
Discontinuity self 24 32 26 27
Continuity self 13 12 13 13
Continuity others 18 16 17 21
others, discontinuity of self). At the end of the maintenance
phase, Robyn’s scores reflected improvements in self-concept (i.e.,
increased continuity with others and a return to initial baseline
levels of discontinuity of self).
Robyn reported high levels of therapeutic alliance on the SRS.
With the exception of session seven (relationship score of 7),
Robyn rated the alliance at a score of 8 or higher [relation-
ship (M = 8.8, SD= 0.63), goals and topics (M = 8.9, SD= 0.31),
approach or method (M = 9, SD= 0), and overall (M = 8.8,
SD= 0.42)].
Overall, visual and statistical analysis of Robyn’s self-reported
functioning indicated limited therapeutic benefits in terms of her
levels of anxiety, depression, helplessness, and perception of ben-
efits. Her level of acceptance of her illness actually declined across
the program. Despite this, Robyn’s quality of life and self-concept
increased throughout the intervention.
SAMUEL
At the time of the intervention, Samuel was a single male work-
ing full-time as a shift-worker. He was in his twenties when he
suffered his first grand-mal seizure, having had no previous his-
tory of seizures or major health concerns. He was diagnosed with
a low-grade (II) oligoastrocytoma in the left temporal lobe and
underwent surgical debulking, chemotherapy, radiation therapy,
and ongoing use of anti-convulsants. He continued to have absence
seizures at least twice per week. Samuel reported frequent panic
attacks (more than one per week) and concerns about his mem-
ory and level of independence. He had been advised that the rate
of tumor progression was unpredictable but was likely to recur
(possibly at a higher grade), which contributed to his anxiety. In
addition, because of the loss of his driver’s license, Samuel felt he
was becoming a burden on his family and friends. Samuel reported
strong family and social relationships and stable employment with
a supportive employer.
There was no significant trend in DASS-21 depression scores
during the baseline phase (Tau-U =−0.048, p= 0.881). A com-
parison of between phase variability (AB) indicated a signif-
icant reduction in level of depression between the baseline
Table 7 | Broader subjective well-being scores for Samuel across
phases.
Measure Initial
baseline
(A)
Final
baseline
(A)
End of
treatment
(B)
End of
maintenance
(C)
FACT-Brain
Physical 23 18 21 27
Social/family 21 21 21 19
Emotional 15 12 16 15
Functional 20 20 22 21
G 79 71 80 82
Brain 39 33 36 26
CDSS
Discontinuity self 28 26 24 26
Continuity self 12 13 13 14
Continuity others 19 16 21 21
and treatment phases (Tau-U =−0.829, p= 0.005). During the
baseline phase, Samuel’s scores were all in the clinical range
(“mild” to “severe”). There was a noticeable reduction in depres-
sive symptoms after the initial treatment session (“telling my
story”). Throughout the treatment and maintenance phases, his
depression scores fluctuated between the “normal” and “mild”
range.
No significant trend was found in the GAD-7 anxiety scores
during the baseline phase (Tau-U = 0.048,p= 0.881). Phase com-
parison indicated a significant reduction in anxiety between
the baseline and treatment phases (Tau-U =−0.7, p= 0.002).
Samuel’s baseline scores were mainly in the “mild” to “moder-
ate” range, although there was a notable reduction in the week
prior to the treatment commencing. His scores fluctuated between
the “normal” and “moderate” range during the treatment phase.
During the maintenance phase, his levels of anxiety were in the
“normal” to “mild” range.
On the ICQ, there was no significant trend found in the base-
line phase for Samuel’s level of helplessness (Tau-U =−0.429,
p= 0.177), acceptance (Tau-U = 0.095, p= 0.764), or perception
of benefit (Tau-U =−0.333, p= 0.293). Phase comparison for
helplessness indicated a significant decrease in levels of helpless-
ness between the baseline and treatment phases (Tau-U =−0.771,
p= 0.008). There was no significant difference between base-
line and treatment phases for acceptance and perceived benefits
(Tau-U = 0.486, p= 0.097; Tau-U = 0.086, p= 0.770).
Samuel’s FACT-G scores declined between the initial and final
baseline assessments (see Table 7). His final baseline FACT-G score
indicated low quality of life relative to the norms. On completion
of the program, Samuel’s FACT-G scores had increased to within
the range of 80–82, thus suggesting improvement in quality of life.
Samuel’s scores indicated slight improvements in self-concept (i.e.,
increased continuity of self, continuity with others, and decreased
discontinuity of self).
Samuel reported high levels of therapeutic alliance on the SRS.
With the exception of session six (where relationship and approach
or method were rated at a score of 7), Samuel rated the alliance
at 8 or higher [relationship (M = 9, SD= 0.94), goals and topics
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(M = 9, SD= 0.67), approach or method (M = 8.9, SD= 0.88),
and overall (M = 8.9, SD= 0.57)].
In summary, visual and statistical analysis of Samuel’s psy-
chological functioning indicated a clear reduction in his levels
of anxiety, depression, and helplessness. Samuel’s levels of accep-
tance remained stable across the program while his perception
of benefits was variable. There were minor improvements in his
self-concept and quality of life.
DISCUSSION
The present study aimed to assess the feasibility and utility of a
telephone-based psychological intervention for individuals with
brain tumor. The evaluation of a telephone-based program was
considered an important extension of the FTF MSoBT program
(37) to provide a potentially more cost-effective option for the
delivery of psychological support services, particularly for people
living outside a major metropolitan area.
As the first study to evaluate a telephone-based psychological
intervention for people with brain tumor, the SCED methodology
provided a rigorous analysis of both within phase (i.e., baseline)
and across phase variability on measures of psychological func-
tioning. All four participants completed the intervention, which
supports the feasibility of tele-based therapy for this population.
Overall, two of the four participants demonstrated significant
gains in mental health and more positive cognitive appraisals
(John and Samuel). The other two participants (Mark and Robyn)
did not demonstrate the hypothesized gains in mental health or
cognitive appraisals. Despite these mixed findings, all participants
reported some degree of improvement in quality of life and high
levels of therapeutic alliance.
The mixed findings in the current research are consistent with
those of previous support interventions that measured changes in
psychological functioning. For example, Locke and colleagues (21)
found that although participants increased their use of compen-
satory strategies, no significant differences in mood were found at
post-intervention. However, unexpectedly, both Mark and Robyn
reported an increase in mood symptoms over the course of treat-
ment and lower levels of acceptance of the brain tumor. It is
possible that discussion of recent and past stressors (e.g., mar-
riage breakdown) heightened their awareness of the implications
of their illness.
It is noteworthy that both Mark and Robyn had tumors located
in the hypothalamic and pituitary areas. Mark identified diffi-
culties with anger outbursts and emotion regulation and Robyn
reported a major change in her emotional experiences prior to
diagnosis (emotional blunting) and after diagnosis (mood swings
and heightened emotions). Numerous studies have identified
that dysregulation of the hypothalamic–pituitary adrenal axis
contributes to mood disorders and difficulties down-regulating
heightened emotional response to negative stimuli (64, 65). As a
result, Mark and Robyn’s ability to apply the emotion regulation
strategies (e.g., cognitive reappraisal) taught during the program
in everyday situations may have been compromised by the nature
of their brain injury.
Additionally, both Robyn and Mark identified cognitive dif-
ficulties that may have reduced the efficacy of telephone-based
support. Mark displayed impaired verbal fluency which may have
impeded his ability to express himself OTT, without the bene-
fit of non-verbal cues. Robyn’s delayed verbal memory impair-
ment may have affected her retention of the content of therapy
sessions. Indeed, she identified in the latter part of the pro-
gram that she is a visual learner and would have preferred FTF
contact with the therapist. Further, Robyn and Mark both per-
ceived a lack of understanding and support from friends, family,
and colleagues. Therefore, despite a relatively favorable prognosis
(i.e., Mark’s long-term survival with no re-growth or progres-
sion; complete removal of Robyn’s benign tumor), they both
reported significant levels of emotional distress. This is consis-
tent with previous research indicating that tumor characteristics
are not consistently related to quality of life or psychological
adjustment (3).
Further to this, impression management and insight were not
measured throughout the program. Hence, it is possible that Mark
was initially reluctant to fully disclose the extent of his distress
during the baseline phase, and became more open about his mood
symptoms and illness appraisals during the treatment phase. The
use of self-report methods relies on the assumption that a par-
ticipant will describe their symptoms and behaviors openly and
accurately (66, 67).
In contrast to Mark and Robyn, both John and Samuel iden-
tified strong support systems through their family and social
networks. Their stress associated with family and friends related to
concerns around the loss of their independence and being a burden
on the people they cared about. They also identified support-
ive workplaces where their roles were adapted to accommodate
their difficulties, thus increasing their sense of life continuity (19).
Psychotherapy techniques assisted with strengthening the roles
identified as important to their sense of identity, despite their less
favorable prognoses and ongoing health and functional difficul-
ties. The tele-based therapy program provided a confidential space
to discuss their hopes, fears, and concerns, without burdening or
upsetting friends and family members.
CLINICAL IMPLICATIONS
Overall, results of this study provide some preliminary support for
the feasibility and utility of telephone-based psychological support
for people with brain tumor. Tele-based therapy may increase the
opportunity to provide interventions to people otherwise unable
to access brain tumor specific support. In the current study, a par-
ticipant living over 4 h away from a major metropolitan area was
able to be involved and he experienced significant gains in his psy-
chological functioning. The tele-based intervention avoided the
need for travel for all participants and the therapist, thus reduc-
ing common barriers to attending regular psychotherapy sessions,
including transport, cost, and health-related barriers. As such,
tele-based therapy may provide a cost and time-effective inter-
vention option for individuals unable to access traditional (FTF)
psychological support (39).
Despite the lack of FTF interaction, high levels of therapeutic
alliance were reported by all four participants, suggesting that a
strong rapport and alliance can be established OTT. As previously
noted, therapeutic alliance is a strong predictor of outcome and
thus the ability to establish good alliance on the telephone supports
the viability of this therapy mode (41).
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Participant feedback on intervention provided further impor-
tant information about feasibility and utility of tele-therapy. As
previously noted, Robyn stated that her first choice would have
been for FTF contact due to her preference for visual processing
of information. In particular, she found it disconcerting to only
hear the therapist’s voice. Robyn regularly sent the therapist pho-
tos or art work via traditional mail (e.g., of a work function, of the
table she sat at during therapy) in an effort to communicate using
visual means. Robyn’s preference for FTF contact is consistent
with research findings that 27.8% of participants had a preference
for FTF contact, although this was not associated with treatment
adherence (41).
In contrast, Mark and Samuel expressed surprise that rap-
port was so easily established without FTF interaction. Samuel
also discussed the benefits of being able to undertake sessions
from his own home, rather than having to travel which was diffi-
cult and upsetting for him due to the loss of his driver’s license.
John expressed gratitude at being able to access psychotherapy,
despite living outside a major metropolitan area. Like Samuel,
he appreciated attending sessions from his own home to avoid
fatigue. Overall, participants’ feedback indicated the importance
of exploring people’s preferences for mode of delivery to enhance
their experience of treatment, especially in the context of cognitive
deficits.
Undertaking psychotherapy via telephone poses a number of
unique challenges. To provide educational handouts, the practi-
tioner needs to send material via traditional mail or email, prior
to or after a session. The relevance of such materials is not always
known in advance. There is a strong reliance on verbal cues (e.g.,
tone of voice) and feedback from the client regarding their under-
standing of the information and skills being trained. As such, there
is the potential for increased preparation time for the therapist
either prior to or after therapy sessions. This is particularly the
case for clients with cognitive difficulties who often benefit from
session summaries and visual aids (e.g., drawing a diagram to
explain concepts) to process and retain new information (11).
Further research is needed to explore the feasibility and utility of
other tele-health or internet-based interventions (e.g., Skype and
video-conferencing).
METHODOLOGICAL CONSIDERATIONS
The current SCED utilized a multiple-baseline design, examining
stability of psychological functioning prior to treatment (51). Mul-
tiple baselines across participants and weekly observations over
an extended period helped to assess for potential extraneous and
confounding factors (49, 50). The combined use of statistical and
visual analyses also increased the methodological rigor of the study,
as recommended by recent methodological guidelines (50).
Despite these strengths, it is important to acknowledge poten-
tial limitations to generalizability. In particular, convenience sam-
pling was used to recruit the four participants who were all proac-
tive in help-seeking. Such characteristics may have enhanced their
continued participation in the program and responsiveness to the
intervention. As such, larger scale research (such as an RCT) should
attempt to broaden intake processes to increase the representative-
ness of participants. Further, while each questionnaire adminis-
tered has been validated in a brain injury, cancer, or community
population, the measurement of change was based on self-report
alone, with no collateral information obtained (48). As such, there
is the potential for socially desirable responses, especially on mea-
sures of rapport and therapeutic alliance. Future research should
attempt to measure outcomes independent from therapy, by use
of a blind assessor or technology (i.e., online questionnaires), to
reduce this potential (50). In addition, future research should
attempt to obtain collateral information from a significant other or
more objective indicators of psychological change (e.g., behavioral
indices).
As the focus of the current research was on feasibility and util-
ity, only a 5-week maintenance period was used. An extended
period of follow-up (i.e., 3- or 6-month follow-up) is needed
to assess more long-term benefits of telephone-based support
interventions. Finally, future research may also benefit from assess-
ing participants’ preference for intervention style (e.g., FTF or
telephone-based). Whilst treatment adherence has not been found
to be linked to preference (41), the outcomes of the intervention
may have been influenced by the preference for FTF therapy. More
generally, the circumstances in which tele-based psychotherapy
is most effective for people with brain tumor need to be better
understood.
SUMMARY
Overall, this study provides some preliminary support concerning
the feasibility, practical benefits, and utility of tele-based psycho-
logical interventions for people with brain tumor. As the current
study utilized four single-case studies, the ability for the find-
ings to be generalized to the broader brain tumor population
is limited. Nonetheless, the in-depth description of each partic-
ipant and their intervention outcomes may enable clinicians to
determine the relevance of the findings for their own setting. The
results of this pilot study may guide future research on accessible
and effective psychotherapy interventions for people with brain
tumor.
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